Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NTOIY | PCG |
|---|---|---|
| Price | $18.12 | $12.35 |
| Change today | ▲ 2.26% | ▲ 0.24% |
| Market cap | $27.23B | $27.20B |
| Return, 3 months | +14.3% | -27.8% |
| Return, year to date | +61.2% | -22.4% |
| Return, 1 year | +92.1% | -22.0% |
| P/E (TTM) | 15.8 | 9.1 |
| P/B | 2.9 | 0.8 |
| P/E percentile vs own 5y | – | 6th |
| Dividend yield | 0.65% | 1.42% |
| Revenue growth (YoY, latest qtr) | – | +0.1% |
| Net profit growth (YoY) | – | +38.6% |
| Gross margin | – | 39.8% |
| Operating margin | – | 20.0% |
| Net margin | – | 11.8% |
| Return on equity | – | 9.9% |
| Analyst target vs. price | – | +49.3% |
| Analyst buy share | – | 30% |
| RSI (14) | 44 | 34 |
| 30-day volatility | 41.9% | 78.7% |
| Max drawdown, 1 year | -18.6% | -37.1% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.